Back to trial details

Intake questionnaire

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

Applying to Karmanos Cancer Institute · Detroit, Michigan

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced Solid Tumors?
3. Are you able to travel to Detroit for study visits?